Humanized mice for modeling human infectious disease: challenges, progress, and outlook.
Nicolas Legrand,Alexander Ploss,Rudi Balling,Pablo D Becker,Chiara Borsotti,Nicolas Brezillon,Jennifer Debarry,Ype de Jong,Hongkui Deng,James P Di Santo,Stephanie Eisenbarth,Elizabeth Eynon,Richard A Flavell,Carlos A Guzman,Nicholas D Huntington,Dina Kremsdorf,Michael P Manns,Markus G Manz,Jean-Jacques Mention,Michael Ott,Chozhavendan Rathinam,Charles M Rice,Anthony Rongvaux,Sean Stevens,Hergen Spits,Hélène Strick-Marchand,Hitoshi Takizawa,Anja U van Lent,Chengyan Wang,Kees Weijer,Tim Willinger,Patrick Ziegler
DOI: https://doi.org/10.1016/j.chom.2009.06.006
IF: 31.316
2009-01-01
Cell Host & Microbe
Abstract:Over 800 million people worldwide are infected with hepatitis viruses, human immunodeficiency virus (HIV), and malaria, resulting in more than 5 million deaths annually. Here we discuss the potential and challenges of humanized mouse models for developing effective and affordable therapies and vaccines, which are desperately needed to combat these diseases.